Showing 1631-1640 of 4848 results for "".
Noah Worcester 2024: Dr. Cohen on Lasers
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-cohen-lasers/24578/Joel L. Cohen, MD, FAAD, summarizes his lecture on laser resurfacing and perioral rejuvenation at the 2024 Noah Worcester Dermatological Society meeting.The Evolution of Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anderson-2--apolesod/19038/Dina Anderson, MD, FAAD, discusses the changing landscape of injectable agents and how patients are more informed about various products and procedures.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.Sleep Disturbances and Psychological Burden of Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses the impact of itch from prurigo nodularis on quality of life through sleep disturbances and mental health effects.A Guidelines-Based Recommendations Algorithm for Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/a-guidelines-based-recommendations-algorithm-for-atopic-dermatitis/48781/Christopher Bunick, MD, FAAD, compares the four approved and recommended biologics and two approved oral JAK inhibitors for treating atopic dermatitis with oral corticosteroidsNoah Worcester 2024: Dr. Bhatia on Actinic Keratosis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bhatia-actinic-keratosis/24585/Neal Bhatia, MD, FAAD, summarizes his lecture on actinic keratosis and photodynamic therapy at the 2024 Noah Worcester Dermatological Society meeting.Evolving Atopic Dermatitis Therapeutic Capabilities
https://practicaldermatology.com/videos/c-suite-chats/evolving-atopic-dermatitis-therapeutic-capabilities/67100/J. Mark Jackson, MD, FAAD, Senior Vice President, Clinical Development for Evommune, discusses the importance of improved efficacy and safety for underserved patients with atopic dermatitis.DermWire TV Extra: Dr. Swanson on BPO
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-extra-dr-swanson-bpo/29166/Practical Dermatology Editorial Board member Elizabeth (Lisa) Swanson, MD, FAAD, addresses the recent news involving the safety of benzoyl peroxide products.How do barrier dysfunction proteins interact with immune dysregulation to sustain AD?
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.Noah Worcester 2024: Dr. Webster on Isotretinoin
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-webster-isotretinoin/24581/Guy Webster, MD, PhD, FAAD, summarizes his lecture on new developments in isotretinoin at the 2024 Noah Worcester Dermatological Society meeting.